It isn’t just artificial intelligence. Chinese biotech companies are now developing drugs faster and cheaper than their US ...

From Chinese social media reeling about Covid to rail contracts in East Africa, here’s a round-up from today’s China and ...

Leading American genomic sequencing firm Illumina says it is evaluating Beijing’s announcement with hope of ‘positive ...

New licensing Guidelines issued by the National Institutes of Health at the end of the Biden Administration could harm ...

The China-US trade war has spread to the biotech industry, as the US BIOSECURE Act looks to dampen Chinese influence on a range of services, including contract manufacturing. Ben Hargreaves ...

The Chinese biotech industry has grown rapidly to become a major hub of research. However, as US-China trade relations continue to deteriorate, Ben Hargreaves asks whether this could stunt ...

The BioSecure Act seeks to reduce US-China biotech ties, creating potential for India to become a biomanufacturing hub.

Rep. Cory Mills (R-FL) is reintroducing legislation to prevent the federal government from giving financial assistance to ...

Shares of Illumina (NASDAQ: ILMN) were falling on Friday. At that time, the S&P 500 had slid by 0.9% and the Nasdaq Composite ...

HYDERABAD: Dr Reddy’s Laboratories SA, the wholly-owned Swiss subsidiary of Hyderabad-based pharma biggie Dr Reddy’s Laboratories Ltd, has entered into a licence agreement with Shanghai Henlius ...

The agreement to co-develop cancer treatments using a RemeGen antibody drug conjugate is regarded as one of the biggest of its kind between a Chinese biotech and a Western firm. It provides for up ...